{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:31:35Z","timestamp":1791297095759,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.vaccine.2013.06.032","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T09:45:23Z","timestamp":1371203123000},"page":"4448-4458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["International collaboration to assess the risk of Guillain Barr\u00e9 Syndrome following Influenza A (H1N1) 2009 monovalent vaccines"],"prefix":"10.1016","volume":"31","author":[{"given":"Caitlin N.","family":"Dodd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana A.","family":"Romio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Vellozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Sturkenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bonhoeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Buttery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Deceuninck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"De Wals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Victoria Gutierrez-","family":"Gimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Heijbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Hviid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Kelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tehri","family":"Kilpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Macartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melisa","family":"Rett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesta Richardson","family":"Lopez-Callada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Gimenez","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann","family":"Storsaeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umapathi","family":"Thirugnanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoline","family":"van der Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Yih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Izurieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.06.032_bib0005","series-title":"WHO\/IVB","author":"World Health Organization, Global Vaccine Safety Blueprint","year":"2012"},{"issue":"20","key":"10.1016\/j.vaccine.2013.06.032_bib0010","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1016\/j.vaccine.2007.02.047","article-title":"The introduction of new vaccines into developing countries. IV: Global access strategies","volume":"25","author":"Mahoney","year":"2007","journal-title":"Vaccine"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2013.06.032_bib0015","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/S0264-410X(00)00467-9","article-title":"Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study","volume":"19","author":"Jacobson","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.032_bib0020","series-title":"A simulation study to compare three self-controlled case series approaches: correction for violation of assumption and explanation of bias","first-page":"22","author":"Hua","year":"2012"},{"key":"10.1016\/j.vaccine.2013.06.032_bib0025","series-title":"International conference on pharmacoepidemiology and therapeutic risk management","article-title":"International Collaborative Case Series Safety Monitoring for Pandemic 2009 H1N1 Vaccines: Estimation of the Risk of Guillain\u2013Barre Syndrome","author":"Dodd","year":"2012"},{"key":"10.1016\/j.vaccine.2013.06.032_bib0030","series-title":"Vaccine safety update, brighton collaboration symposium","article-title":"A proof-of-concept collaborative international study for the post-licensure epidemiological assessment of the safety of newly introduced vaccines","author":"Izurieta","year":"2012"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2013.06.032_bib0035","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0264-410X(02)00449-8","article-title":"The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI)","volume":"21","author":"Bonhoeffer","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.06.032_bib0040","first-page":"339","article-title":"Assessing the severity of the novel influenza A\/H1N1 pandemic","author":"Garske","year":"2009","journal-title":"BMJ"},{"issue":"30","key":"10.1016\/j.vaccine.2013.06.032_bib0045","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.vaccine.2010.04.083","article-title":"Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009\u20132010 and comparison with previous estimates and global action plan targets","volume":"28","author":"Partridge","year":"2010","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2013.06.032_bib0050","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/sim.2302","article-title":"Tutorial in biostatistics: the self-controlled case series method","volume":"25","author":"Whitaker","year":"2006","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2013.06.032_bib0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain\u2013Barr\u00e9 syndrome following vaccination in the national influenza immunization program: United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.vaccine.2013.06.032_bib0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain\u2013Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2013.06.032_bib0065","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2307\/2533328","article-title":"Relative incidence estimation from case series for vaccine safety evaluation","volume":"51","author":"Farrington","year":"1995","journal-title":"Biometrics"},{"key":"10.1016\/j.vaccine.2013.06.032_bib0070","doi-asserted-by":"crossref","first-page":"d3908","DOI":"10.1136\/bmj.d3908","article-title":"Guillain\u2013Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case\u2013control study in Europe","volume":"343","author":"Dieleman","year":"2011","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.vaccine.2013.06.032_bib0075","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1377\/hlthaff.2012.0104","article-title":"Success of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillance","volume":"31","author":"Salmon","year":"2012","journal-title":"Health Aff (Millwood)"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.06.032_bib0080","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pds.2323","article-title":"The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise","volume":"21","author":"Nguyen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1016\/j.vaccine.2013.06.032_bib0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/oxfordjournals.aje.a116479","article-title":"Confounding in studies of adverse reactions to vaccines","volume":"136","author":"Fine","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.06.032_bib0090","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) \u2013 United States, 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.vaccine.2013.06.032_bib0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/pds.2330","article-title":"When should case-only designs be used for safety monitoring of medical products?","volume":"21","author":"Maclure","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.vaccine.2013.06.032_bib0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/biostatistics\/kxn013","article-title":"Case series analysis for censored, perturbed, or curtailed post-event exposures","volume":"10","author":"Farrington","year":"2009","journal-title":"Biostatistics"},{"issue":"3","key":"10.1016\/j.vaccine.2013.06.032_bib0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"20","key":"10.1016\/j.vaccine.2013.06.032_bib0110","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","article-title":"Guillain\u2013Barre syndrome following influenza vaccination","volume":"292","author":"Haber","year":"2004","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.vaccine.2013.06.032_bib0115","doi-asserted-by":"crossref","first-page":"574","DOI":"10.5694\/mja12.10534","article-title":"Guillain\u2013Barre syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series","volume":"197","author":"Crawford","year":"2012","journal-title":"Med J Aust"},{"issue":"10","key":"10.1016\/j.vaccine.2013.06.032_bib0120","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2105\/AJPH.2011.300510","article-title":"Surveillance for Guillain\u2013Barre syndrome after influenza vaccination among the Medicare population: 2009\u20132010","volume":"102","author":"Burwen","year":"2012","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2013.06.032_bib0125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.2012.7342","article-title":"Risk of Guillain\u2013Barre syndrome following H1N1 influenza vaccination in Quebec","volume":"308","author":"De Wals","year":"2012","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.vaccine.2013.06.032_bib0130","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/aje\/kws195","article-title":"Risk of confirmed Guillain\u2013Barr\u00e9 syndrome following receipt of monovalent inactivated Influenza A (H1N1) and Seasonal Influenza Vaccines in the Vaccine Safety Datalink Project: 2009\u20132010","volume":"175","author":"Greene","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/j.vaccine.2013.06.032_bib0135","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/aje\/kws196","article-title":"Guillain\u2013Barre syndrome during the 2009\u20132010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans","volume":"175","author":"Wise","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/j.vaccine.2013.06.032_bib0140","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/aje\/kws197","article-title":"Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System: 2009\u20132010","volume":"175","author":"Yih","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.vaccine.2013.06.032_bib0145","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/pds.3220","article-title":"The risk of Guillain\u2013Barre syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009\u20132010 seasonal influenza vaccines: results from self-controlled analyses","volume":"21","author":"Tokars","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2013.06.032_bib0150","doi-asserted-by":"crossref","first-page":"d5956","DOI":"10.1136\/bmj.d5956","article-title":"Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden","volume":"343","author":"Bardage","year":"2011","journal-title":"BMJ"},{"issue":"45","key":"10.1016\/j.vaccine.2013.06.032_bib0155","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.1016\/j.vaccine.2011.08.069","article-title":"Guillain\u2013Barre syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series","volume":"29","author":"Andrews","year":"2011","journal-title":"Vaccine"},{"issue":"9876","key":"10.1016\/j.vaccine.2013.06.032_bib0160","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(12)62189-8","article-title":"Association between Guillain-Barre syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis","volume":"381","author":"Salmon","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2013.06.032_bib0165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vaccine.2011.10.062","article-title":"Antibody persistence and response to 2010\u20132011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children","volume":"30","author":"Gilca","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2013.06.032_bib0170","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/aje\/kwn310","article-title":"Investigation of the temporal association of Guillain\u2013Barr\u00e9 syndrome with influenza vaccine and influenza like illness using the United Kingdom general practice research database","volume":"169","author":"Stowe","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"S1","key":"10.1016\/j.vaccine.2013.06.032_bib0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ana.410090707","article-title":"Guillain\u2013Barr\u00e9 syndrome: its epidemiology and associations with influenza vaccination","volume":"9","author":"Schonberger","year":"1981","journal-title":"Ann Neurol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.06.032_bib0180","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/513793","article-title":"Clinical and epidemiologic features of Guillain\u2013Barr\u00e9 syndrome","volume":"176","author":"Hughes","year":"1997","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2013.06.032_bib0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000339248","article-title":"Guillain\u2013Barre syndrome incidence in a large United States cohort (2000\u20132009)","volume":"39","author":"Shui","year":"2012","journal-title":"Neuroepidemiology"},{"issue":"7","key":"10.1016\/j.vaccine.2013.06.032_bib0190","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/529197","article-title":"Biology of immune responses to vaccines in elderly persons","volume":"46","author":"Weinberger","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"20","key":"10.1016\/j.vaccine.2013.06.032_bib0195","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2013.06.032_bib0200","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1056\/NEJMoa0904252","article-title":"Pneumonia and respiratory failure from swine-origin Influenza A (H1N1) in Mexico","volume":"361","author":"Perez-Padilla","year":"2009","journal-title":"New Engl J Med"},{"issue":"9707","key":"10.1016\/j.vaccine.2013.06.032_bib0205","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(09)61638-X","article-title":"Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis","volume":"374","author":"Echevarr\u00eda-Zuno","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2013.06.032_bib0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2875-12-11","article-title":"Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S\/AS02D malaria vaccine in infants living in a malaria-endemic region","volume":"12","author":"Abdulla","year":"2013","journal-title":"Malar J"},{"issue":"44","key":"10.1016\/j.vaccine.2013.06.032_bib0215","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.1016\/j.vaccine.2010.08.062","article-title":"Post-licensure comparison of the safety profile of diphtheria\/tetanus\/whole cell pertussis\/haemophilus influenza type b vaccine and a 5-in-1 diphtheria\/tetanus\/acellular pertussis\/haemophilus influenza type b\/polio vaccine in the United Kingdom","volume":"28","author":"Andrews","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2013.06.032_bib0220","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1542\/peds.2009-1496","article-title":"Lack of association between acellular pertussis vaccine and seizures in early childhood","volume":"126","author":"Huang","year":"2010","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.vaccine.2013.06.032_bib0225","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1023\/A:1015691619745","article-title":"Does oral polio vaccine cause intussusception in infants? Evidence from a sequence of three self-controlled cases series studies in the United Kingdom","volume":"17","author":"Andrews","year":"2001","journal-title":"Eur J Epidemiol"},{"issue":"25","key":"10.1016\/j.vaccine.2013.06.032_bib0230","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","article-title":"The Guillain\u2013Barre syndrome and the 1992\u20131993 and 1993\u20131994 influenza vaccines","volume":"339","author":"Lasky","year":"1998","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13008104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13008104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T08:23:38Z","timestamp":1539591818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13008104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":46,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0264410X13008104"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International collaboration to assess the risk of Guillain Barr\u00e9 Syndrome following Influenza A (H1N1) 2009 monovalent vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}